Logo

Invitrogen Completes Molecular Probes Acquisition

Aug 22, 2003

NEW YORK, Aug. 22 (GenomeWeb News) - Invitrogen announced today that it had completed its acquisition of Molecular Probes.

 

"As a leader in life sciences consumables, we believe that Invitrogen's worldwide sales, marketing and distribution capabilities will accelerate the penetration of Molecular Probes' core technologies into new markets," said Invitrogen CEO Greg Lucier in a statement that also reaffirmed the company's financial guidance for 2003.

Breaking News
The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.